» Articles » PMID: 26987792

Relationship Between Local Production of MicroRNA-328 and Atrial Substrate Remodeling in Atrial Fibrillation

Overview
Journal J Cardiol
Publisher Elsevier
Date 2016 Mar 19
PMID 26987792
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The underlying mechanism of atrial substrate remodeling in atrial fibrillation (AF) remains unknown. In this study, we investigated whether local and systemic levels of microRNA (miR) might be associated with the presence of AF and with left atrial (LA) substrate properties.

Methods: Blood from the periphery, pulmonary vein (PV), and left atrial appendage (LAA) was sampled from 30 patients with AF undergoing PV isolation, and from 10 control subjects with Wolff-Parkinson-White syndrome and without AF. We measured peripheral, PV, and LAA plasma levels of miR-1, -26, -133a, -328, and -590 by reverse transcription-polymerase chain reaction. LA global contact mapping during sinus rhythm was performed before PV isolation.

Results: Plasma levels of miR-328 were higher in patients with AF than in control subjects. Plasma miR-328 levels were significantly higher in the LAA than in the periphery and PV in patients with AF, but not in control subjects. Plasma miR-1 levels were also higher in the LAA than in the PV in AF patients. Interestingly, LAA plasma levels of miR-328 showed a positive correlation with the LA voltage zone index (area with voltage <0.5mV divided by total LA surface area) and a weak correlation with LA volume.

Conclusion: Local production of miR-328 in the left atrium may be involved in the process of atrial remodeling in patients with AF.

Citing Articles

MicroRNAs in atrial fibrillation - have we discovered the Holy Grail or opened a Pandora's box?.

Balan A, Scridon A Front Pharmacol. 2025; 16:1535621.

PMID: 40012622 PMC: 11861496. DOI: 10.3389/fphar.2025.1535621.


miR-338-5p regulated the NF-κB/MAPK pathway to alleviate inflammation and oxidative stress by targeting IL-6 in rats with atrial fibrillation.

Zhang Y, Yao Y, Wei J, Zhang Z 3 Biotech. 2024; 14(7):182.

PMID: 38947734 PMC: 11213847. DOI: 10.1007/s13205-024-04024-4.


Exosomal miRNA Changes Associated with Restoration to Sinus Rhythm in Atrial Fibrillation Patients.

Tsai P, Ko A, Chen Y, Chiu C, Yeh Y, Tsai F Int J Mol Sci. 2024; 25(7).

PMID: 38612670 PMC: 11011649. DOI: 10.3390/ijms25073861.


MicroRNAs: Midfielders of Cardiac Health, Disease and Treatment.

Asjad E, Dobrzynski H Int J Mol Sci. 2023; 24(22).

PMID: 38003397 PMC: 10671258. DOI: 10.3390/ijms242216207.


Circulating miR-451a Expression May Predict Recurrence in Atrial Fibrillation Patients after Catheter Pulmonary Vein Ablation.

Lage R, Cebro-Marquez M, Vilar-Sanchez M, Gonzalez-Melchor L, Garcia-Seara J, Martinez-Sande J Cells. 2023; 12(4).

PMID: 36831306 PMC: 9953933. DOI: 10.3390/cells12040638.